Bnp Paribas Arbitrage, Snc »

Arrivent Biopharma shares owned by Bnp Paribas Arbitrage, Snc

Quarter-by-quarter ownership of Arrivent Biopharma (AVBP) shares owned by Bnp Paribas Arbitrage, Snc from 13F filings

Historical chart of Bnp Paribas Arbitrage, Snc investment in Arrivent Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arrivent Biopharma held by Bnp Paribas Arbitrage, Snc consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrivent Biopharma by Bnp Paribas Arbitrage, Snc

Quarter filed Position value Share count Share price at filing
2024-09-30 $516k 22k 23.50
2024-06-30 $307k 17k 18.55
2024-03-31 $83k 4.7k 17.86

More positions owned by Bnp Paribas Arbitrage, Snc

NVIDIA Corp Equity (NVDA)
Microsoft Corp Equity (MSFT)
Apple Equity (AAPL)
Meta Platforms Equity (META)
Amazon.com Equity (AMZN)
Tesla Equity (TSLA)
iShares Russell 2000 ETF Fund (IWM)
Broadcom Equity (AVGO)
Alphabet Equity (GOOGL)
Alphabet Equity (GOOG)
Berkshire Hathaway Equity (BRK.B)
JPMorgan Chase & Co Equity (JPM)
Advanced Micro Devices Equity (AMD)
NASDAQ 100 Index Fund (QQQ)
SPDR S&P 500 ETF Trust Fund (SPY)

View all positions for Bnp Paribas Arbitrage, Snc

Top funds holding Arrivent Biopharma

Hillhouse Capital Advisors
OrbiMed Advisors
Octagon Capital Advisors
BlackRock
Suvretta Capital Management
Sofinnova Ventures
Novo A/S
General Catalyst Group Management
Sc China Holding
BlackRock
Vanguard Group
Geode Capital Management
Cormorant Asset Management
Perceptive Advisors
Northern Trust

View all funds holding Arrivent Biopharma